Surmodics answers US FTC amended in-house complaint, says GTCR deal is procompetitive
Surmodics answered the US Federal Trade Commission's amended administrative complaint challenging its sale to private equity firm GTCR, stating that the deal is procompetitive and denying the agency’s allegations. The FTC...To view the full article, register now.
Already a subscriber? Click here to view full article